Synopsis : IQVIA announced an agreement today with argenx SE. The multi-year contract covers a unique collaboration for the development of new…
company
-
-
Novo Nordisk
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines
by adminby adminSummary : Novo Nordisk announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of…
-
Summary : Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced…
-
Global Market
AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war
by adminby adminSummary : Since the invasion of Ukraine, hundreds of companies have announced a pause or withdrawal of businesses in Russia. Drugmakers Eli…
-
Pharma Science & Research
NICE to improve diagnosis for foetal alcohol spectrum disorder
by adminby adminSummary : Better treatment for conditions experienced by individuals who were exposed to alcohol before birth The National Institute for Health and…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
CompaniesModernaPatent LitigationPatentsPfizer
Alnylam Files Patent Infringement Lawsuits Against Pfizer, Moderna
by adminby adminSummary : Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc, claiming their multibillion-dollar…
-
Summary : Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for…
-
Summary : The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however,…
-
CompaniesMerck & CoMerger / Acquisition
Merck & Co pens $340m pain drug deal with KCL and Wellcome
by adminby adminSummary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…